Home/ Supplements/ Vitamin K/ Vitamin K2 MK-7-100 mcg

Vitamin K2 MK-7-100 mcg

product on market Capsule Biophix Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 (MK-7) is researched for its role in supporting bone health and cardiovascular function by regulating calcium distribution. There is moderate evidence suggesting it helps direct calcium into bones and away from arterial walls. This specific formulation provides a standard 100 mcg dose of the nutrient.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 MK-7-100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veg Capsule(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Cellulose Rice Flour Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: For adults take 1 Veg Capsule daily, preferably with meals.

Warnings & Precautions

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication (especially anti-coagulant drugs such as warfarin, coumadin, heparin), or have a medical condition.

Keep out of reach of children.

Contains soy

Produced in a GMP facility that processes other ingredients containing these allergens.

Do not eat freshness packet. Keep in bottle.

Formulation Notes

Recent researched has revealed Vitamin K's beneficial effects on bone and cardiovascular health. Biophix MK-7 contains a highly biologically active form of Vitamin K-2 derived from natto, a traditional Japanese fermented soyfood.

Manufactured in an GMP Inspected Facility

Specially formulated from Natto Highly bioactive form of Vitamin K-2 Vitamin

GMP Tested

Not manufactured with wheat, gluten, milk, egg, fish, shellfish or tree nut ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Additional Information

Made in USA

Phone: (US) 305-861-0898

Store in a cool, dry place after opening.

Please recycle.

Metadata

Product Details

UPC / SKUX0014E09ET
DSLD Entry Date2023-03-22
Product TypeVitamin
FormCapsule
BrandBiophix
DSLD ID276094
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.